When Must a Change Notification Be Submitted for a Medical Device Change?

Short answer: A change notification for a medical device is generally required when the change may affect the product's safety, performance, intended use, design, manufacturing process, materials, software version, labeling or instructions for use, quality system, or registration certificate information. Because countries classify and submit changes differently, manufacturers should first conduct a change impact assessment, then decide whether the change can be handled by internal records, a notification, a supplement or variation, or a new registration.

Prepared by the AIMEILI Regulatory Editorial Team based on public regulatory sources, registration practice, and international medical device registration reference materials.

Published: 2026-07-08 09:00 | Updated: 2026-07-08 09:00

This FAQ addresses priority questions that companies need to assess in international medical device registration, documentation preparation, compliance pathways, and post-market maintenance.

Key Summary

Whether a medical device change requires a change notification depends on whether the change affects product safety, performance, intended use, design, manufacturing process, materials, software version, labeling or instructions for use, quality system, or registration certificate information. Different countries have different change classification and submission requirements. Companies should first perform a change impact assessment, then determine whether the change is handled through internal documentation, notification, supplement or variation, or re-registration.

Who Should Read This

This content is intended for manufacturers, regulatory affairs professionals, overseas business leaders, and CRO teams that are planning international medical device registration, preparing to enter GHWP member states and key markets, or assessing documentation gaps and registration pathways.

Decision Logic

Companies should first clarify the target country, product risk class, intended use, existing registration basis, and commercial launch plan. They should then determine the applicable regulatory pathway, expected documentation depth, local agent requirements, and post-market maintenance obligations. The same product may have different classifications and evidence requirements in different countries, so conclusions from domestic registration cannot simply be applied globally.

Documentation Priorities

• Identify the change type: design, materials, software, manufacturing, labeling, certificate information, and other relevant areas.
• Assess the change's impact on safety, performance, and risk management.
• Check the target country's requirements for change notification and implementation timing.
• Retain change assessment, verification, and approval records.

Common Misunderstandings

Common misunderstandings include mechanically preparing documents only against a checklist, failing to classify the product first, overlooking local agent and labeling requirements, underestimating supplemental testing and translation workload, and treating the registration certificate as a one-time task while neglecting post-market maintenance.

AIMEILI Viewpoint

AIMEILI recommends that companies establish a multi-country change assessment table to avoid implementing a change in one country while forgetting that another market requires advance notification or a supplemental submission.

Continue Reading

Previous: What should be considered when selling a medical device software app on EU online platforms?

Next: How do UDI and product classification codes affect overseas registration?

Recommended Reading

• What should be considered when selling a medical device software app on EU online platforms?
• How should performance evaluation documentation for overseas IVD product registration be prepared?
• How can medical device cybersecurity documentation be prepared in advance?
• What documents are commonly required for international medical device registration?
• What do clinical evaluation documents usually focus on?
• What should companies prepare before TGA medical device registration in Australia?

Back to FAQ Center

News and Updates | Contact AIMEILI

Content Review and Scope

Content author: AIMEILI Regulatory Editorial Team

Professional review: AIMEILI Medical Device International Registration Project Team

Source principle: Official regulatory authorities, international organizations, standards organizations, and public regulatory materials are prioritized; industry media and project experience are used only as supporting references for judgment.

Scope: This article is intended for preliminary understanding, documentation preparation, and project planning. It does not replace the formal requirements of the target country's regulatory authority, testing conclusions, or legal advice.